2-214792458-TAAAAA-TAAAAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_000465.4(BARD1):​c.216-14dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 2 hom., cov: 0)
Exomes 𝑓: 0.020 ( 0 hom. )

Consequence

BARD1
NM_000465.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.884

Publications

4 publications found
Variant links:
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • familial ovarian cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 2-214792458-T-TA is Benign according to our data. Variant chr2-214792458-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1198408.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00394 (502/127258) while in subpopulation EAS AF = 0.0095 (40/4212). AF 95% confidence interval is 0.00717. There are 2 homozygotes in GnomAd4. There are 239 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 502 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
NM_000465.4
MANE Select
c.216-14dupT
intron
N/ANP_000456.2
BARD1
NM_001282543.2
c.159-14dupT
intron
N/ANP_001269472.1
BARD1
NM_001282545.2
c.215+4602dupT
intron
N/ANP_001269474.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BARD1
ENST00000260947.9
TSL:1 MANE Select
c.216-14_216-13insT
intron
N/AENSP00000260947.4
BARD1
ENST00000617164.5
TSL:1
c.159-14_159-13insT
intron
N/AENSP00000480470.1
BARD1
ENST00000613706.5
TSL:1
c.216-14_216-13insT
intron
N/AENSP00000484976.2

Frequencies

GnomAD3 genomes
AF:
0.00394
AC:
501
AN:
127228
Hom.:
2
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00750
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.000650
Gnomad EAS
AF:
0.00947
Gnomad SAS
AF:
0.00267
Gnomad FIN
AF:
0.00778
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00190
Gnomad OTH
AF:
0.00230
GnomAD2 exomes
AF:
0.0148
AC:
1425
AN:
96390
AF XY:
0.0143
show subpopulations
Gnomad AFR exome
AF:
0.0192
Gnomad AMR exome
AF:
0.0168
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.0348
Gnomad FIN exome
AF:
0.0158
Gnomad NFE exome
AF:
0.0129
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
AF:
0.0204
AC:
25501
AN:
1250056
Hom.:
0
Cov.:
0
AF XY:
0.0197
AC XY:
12220
AN XY:
619326
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0270
AC:
713
AN:
26374
American (AMR)
AF:
0.0156
AC:
374
AN:
23974
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
363
AN:
21950
East Asian (EAS)
AF:
0.0288
AC:
945
AN:
32806
South Asian (SAS)
AF:
0.0165
AC:
1110
AN:
67354
European-Finnish (FIN)
AF:
0.0237
AC:
899
AN:
37940
Middle Eastern (MID)
AF:
0.0130
AC:
53
AN:
4090
European-Non Finnish (NFE)
AF:
0.0203
AC:
19972
AN:
983896
Other (OTH)
AF:
0.0207
AC:
1072
AN:
51672
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.266
Heterozygous variant carriers
0
2836
5672
8508
11344
14180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00394
AC:
502
AN:
127258
Hom.:
2
Cov.:
0
AF XY:
0.00391
AC XY:
239
AN XY:
61152
show subpopulations
African (AFR)
AF:
0.00752
AC:
259
AN:
34446
American (AMR)
AF:
0.00176
AC:
23
AN:
13040
Ashkenazi Jewish (ASJ)
AF:
0.000650
AC:
2
AN:
3076
East Asian (EAS)
AF:
0.00950
AC:
40
AN:
4212
South Asian (SAS)
AF:
0.00268
AC:
11
AN:
4104
European-Finnish (FIN)
AF:
0.00778
AC:
51
AN:
6552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00190
AC:
112
AN:
59072
Other (OTH)
AF:
0.00228
AC:
4
AN:
1754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000533
Hom.:
67

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Familial cancer of breast (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56130510; hg19: chr2-215657182; API